Bioequivalence and Bioavailability Forum 02:54 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

manusyriac
Junior

India,
2018-03-08 10:20

Posting: # 18505
Views: 554
 

 IP retention EU regulatory requirements [Regulatives / Guidelines]

Hi All,

I would like to seek your help in getting your thoughts on the EU regulatory requirements on the investigational medicinal product retention at sponsor manufacturing sites. Especially my focus area is the quantity of IP to be stored at manufacturing site.

Please guide me.

Regards
Manu
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,882 posts in 4,026 threads, 1,271 registered users;
online 26 (0 registered, 26 guests [including 23 identified bots]).

Some scientists claim that hydrogen, because it is so plentiful,
is the basic building block of the universe.
I dispute that. I say there is more stupidity than hydrogen,
and that is the basic building block of the universe.    Frank Zappa

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed